Medium-chain triglycerides

Medium-chain triglycerides has been studied in 40 papers since 2012: 16 trials and 1 observational study in people, 7 in animals, 15 reviews; 11 in the past year. Its furthest trials in people are at early phase 1. The newest story, Oct 2, 2026: “Alpha-synuclein impairs triglyceride metabolism and mitochondrial structure in aging nematodes”.

InterventionEarly phase 1

40 papers study it13 more mention it44 findingsUpdated

PubChem

1 new paper in 30 daysSee all 52 papers on medium-chain triglycerides

At a glance

Medium-chain triglycerides increase muscle mass and grip strength in human trials, with independent labs reporting both changes. Human cognitive outcomes range from improvement to no clear effect; a mouse study shows no clear lifespan effect at tested concentrations. Some papers declare company ties, and some authors work for companies including Nisshin OilliO Group and Meiji.

44 findings in 18 papers from 2012 to 2026, 2 of them since July 2026

Independent labs found the same change in people. 9 independent labs in 4 countries; 2 trials, none about aging, 1 with no results posted.

“As a result of the 12-week intervention, physical function (PF), general health (GH), vitality (VT) and mental component summary (MCS) showed significant increases in scores in all MCT supplement groups compared to the control group, either in actual or change scores.”
Effect of medium-chain triglycerides supplements and walking on health-related quality of life in sedentary, healthy middle-aged, and older adults with low BMIs: a randomized, double-blind, placebo-controlled, parallel-group trialFrontiers in nutrition2023doi:10.3389/fnut.2023.1296896

1 of its findings points the other way.

Humans: replicated by independent labs. Worms or flies and mice: a single group. Cells: nothing yet.
  • 9 independent labs in 4 countries
  • 1 finding against
  • 2 trials, none about aging, 1 with no results posted
  • Funders: Tohoku University Center for Gender Equality Promotion and others
  • 6 of 37 findings with company ties
  • Human trial16
  • Humans1
  • Animals6
  • Model organisms1

10 studies gave medium-chain triglycerides to people and measured what changed.

What changedDesignPeopleSource

up: Increases body mass indexfrom 18.8 ± 2.2 to 19.7 ± 2.3 kg/m2 (p=0.002)

up: Improves grip strengthfrom 9.9 ± 3.9 to 11.1 ± 5.2 kg (p=0.049)

no change: Has no effect on cognitive function

Trial5 months16 peopleolderOlder adults; undernourished or at risk of malnutritionCureus, Dec 18, 2025

up: Increases muscle density

Randomized trial3 consecutive months68 peoplefemales/males: 22/10 in the MCT group and 21/10 in the placebo group65–80 yearsRight-handed older adults without dementia or mild cognitive impairment, and with full autonomy in activities of daily livingNutrients, May 18, 2025

up: Increases body weightMCTs 1.2 kg vs. LCTs 0.2 kg

up: Increases muscle mass

up: Improves grip strengthMCTs 1.6 kg vs. LCTs 0.3 kg

Review of trials3.0-mo interventionBothmean age around 85 yearsParticipants who resided in this nursing home and required special care from a helperFrontiers in nutrition, Dec 4, 2023

up: Improves health-related quality of life

up: Increases knee extension strength

Randomized trial12-week120 peopleaged 60–74 yearsOlder adultsFrontiers in nutrition, Nov 23, 2023

up: Improves knee extension strength

up: Improves grip strength

Randomized trial12 weeks120 peopleaged between 60 and 75 yearsJapanese males and females aged between 60 and 75 years with BMIs between 19 kg/m2 and 24 kg/m2Nutrients, Jul 24, 2023

What did mouse lifespan tests of medium-chain triglycerides find?

NIA ITP

The NIA Interventions Testing Program ran 1 arm in 2007; the change in median lifespan ran from −1% to +2%.

What did studies of medium-chain triglycerides find?

29

Studies of medium-chain triglycerides measured 29 outcomes; the most studied are cognitive function (5 studies), grip strength (3) and glycolysis (2).

Cognitive function

upin humans3no changein humans2

5 studies
  1. Medium-chain triglycerides showed no clear effect on cognitive function in humans (undernourished or at risk of malnutrition).

    “No significant changes were observed in cognitive function in either group.”

    Human trialundernourished or at risk of malnutritionsnack containing MCTs (135-136 kcal, 0.4 g protein)10 g/day5 months

    A Pilot Study on the Effects of Medium-Chain Triglyceride-Enriched Oral Nutritional Supplementation on Nutritional Status, Physical Function, and Cognitive Function in Older Facility Residents

    Cureus

  2. Medium-chain triglycerides showed no clear effect on cognitive function in humans.

    “no time × group interaction was observed in cognitive and other gait parameters”

    Human trialjelly stick18 g/day3 months

    Impact of medium-chain triglycerides on gait performance and brain metabolic network in healthy older adults: a double-blind, randomized controlled study

    GeroScience

  3. Medium-chain triglycerides improve cognitive function in humans (frail elderly nursing home residents) (+3.5 points MMSE; difference vs LCT group significant (P < 0.05)).

    “MCT supplementation increased the Mini-Mental State Examination (MMSE) score by 3.5 points at the 3-mo intervention from baseline (P < 0.001)”

    Human trialfrail elderly nursing home residents6 g/d3 monthsn = 64

    Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial

    The Journal of nutrition

  4. Medium-chain triglycerides improve cognitive function in humans (Alzheimer's disease or mild cognitive impairment).

    “Most MCT supplements did show cognitive improvements, although only after 6 months of adherence.”

    ReviewAlzheimer's disease or mild cognitive impairmentsupplements6 months

    Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

    Applied nursing research : ANR

  5. Medium-chain triglycerides improve cognitive function in humans.

    “proven to benefit both individuals with normal cognition and those suffering from mild cognitive impairment, Alzheimer's disease, and other cognitive disorders.”

    ReviewNormal cognition, mild cognitive impairment, Alzheimer's disease, or other cognitive disorders

    Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review

    Frontiers in nutrition

Grip strength

upin humans3

3 studies
  1. Medium-chain triglycerides improve grip strength in humans (undernourished or at risk of malnutrition) (from 9.9 ± 3.9 to 11.1 ± 5.2 kg (p=0.049)).

    “Grip strength in the intervention group increased from 9.9 ± 3.9 kg at baseline to 11.1 ± 5.2 kg after 5 months”

    Human trialundernourished or at risk of malnutritionsnack containing MCTs (135-136 kcal, 0.4 g protein)10 g/day5 months

    A Pilot Study on the Effects of Medium-Chain Triglyceride-Enriched Oral Nutritional Supplementation on Nutritional Status, Physical Function, and Cognitive Function in Older Facility Residents

    Cureus

  2. Medium-chain triglycerides improve grip strength in humans (MCTs 1.6 kg vs. LCTs 0.3 kg).

    “right-hand grip strength (MCTs 1.6 kg vs. LCTs 0.3 kg, p = 0.017”

    Human trial3.0-mo intervention

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

  3. Medium-chain triglycerides improve grip strength in humans (relative to 6 g LCTs/day) (MCTs 1.6 vs. LCTs 0.3 kg, p = 0.017).

    “right-hand grip strength (MCTs 1.6 vs. LCTs 0.3 kg, p = 0.017)”

    Human trialrelative to 6 g LCTs/day6 g/day3 months

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

  4. Medium-chain triglycerides improve grip strength in humans.

    “Although no intergroup differences were observed in grip strength, the left-hand maximum grip strength significantly increased from baseline in the high-dose octanoic acid group and the decanoic acid group that consumed 6 g of MCT per day.”

    Human trial12 weeks

    A Randomized, Double-Blind, Controlled Trial Assessing If Medium-Chain Triglycerides in Combination with Moderate-Intensity Exercise Increase Muscle Strength in Healthy Middle-Aged and Older Adults

    Nutrients

Glycolysis

downin humans2

2 studies
  1. Medium-chain triglycerides decrease glycolysis in humans (post-intervention).

    “For post-intervention glucose metabolism, MCT decreased the SUV mean in the lower skeletal muscles (psoas and vastus medialis), with a slight elevation in the liver, but no significant changes in blood glucose levels.”

    Human trialpost-interventionpsoas and vastus medialis3 consecutive monthsn = 68

    Medium-Chain Triglyceride Dietary Supplements Reduce Glucose Metabolism of Gait-Related Skeletal Muscle in Older Adults: A Longitudinal ¹⁸F-FDG PET/CT Analysis

    Nutrients

  2. Medium-chain triglycerides decrease glycolysis in humans (healthy) (p < 0.001).

    “MCT supplementation for 3 months decreased the SUVmean (p < 0.001)”

    Human trialhealthyjelly stickskeletal muscle18 g/day3 monthsn = 63

    Medium-Chain Triglyceride Dietary Supplements Reduce Glucose Metabolism of Gait-Related Skeletal Muscle in Older Adults: A Longitudinal ¹⁸F-FDG PET/CT Analysis

    Nutrients

  3. Medium-chain triglycerides inhibit glycolysis in humans (P < 0.001).

    “MCT led to suppressed glucose metabolism in the right sensorimotor cortex compared with the control (P < 0.001)”

    Human trialjelly stickright sensorimotor cortex18 g/day3 months

    Impact of medium-chain triglycerides on gait performance and brain metabolic network in healthy older adults: a double-blind, randomized controlled study

    GeroScience

More on Glycolysis

Physical function

upin humans2

2 studies
  1. Medium-chain triglycerides improve physical function in humans (frail elderly nursing home residents) (+39 ± 42 s (breakfast) and +20 ± 32 s (dinner)).

    “right knee extension time by 39 ± 42 s (P<0.01) and 20 ± 32 s (P<0.05)”

    Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37

    Effects of Timing of Medium-Chain Triglycerides (8:0 and 10:0) Supplementation during the Day on Muscle Mass, Function and Cognition in Frail Elderly Adults

    The Journal of frailty & aging

  2. Medium-chain triglycerides improve physical function in humans (frail).

    “supplementation with a low dose (6 g/day) of medium-chain triglycerides (MCTs; C8:0 and C10:0) given at a meal increased muscle mass and function”

    Reviewfrail6 g/day3-month

    Possible Extracellular Signals to Ameliorate Sarcopenia in Response to Medium-Chain Triglycerides (8:0 and 10:0) in Frail Older Adults

    Nutrients

Muscle mass

upin humans2

2 studies
  1. Medium-chain triglycerides increase muscle mass in humans (relative to 6 g LCTs/day) (MCTs 1.4 vs. LCTs-0.7 cm2, p = 0.002).

    “right arm muscle area (MCTs 1.4 vs. LCTs-0.7 cm2, p = 0.002)”

    Human trialrelative to 6 g LCTs/dayright arm6 g/day3 months

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

  2. Medium-chain triglycerides increase muscle mass in humans (frail elderly nursing home residents) (+1.1 ± 0.8 cm2 (breakfast) and +1.6 ± 2.5 cm2 (dinner)).

    “MCT supplementation in breakfast and dinner groups respectively increased right arm muscle area from baseline by 1.1 ± 0.8 cm2 (P<0.001) and 1.6 ± 2.5 cm2 (P<0.001)”

    Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37

    Effects of Timing of Medium-Chain Triglycerides (8:0 and 10:0) Supplementation during the Day on Muscle Mass, Function and Cognition in Frail Elderly Adults

    The Journal of frailty & aging

Knee extension strength

upin humans2

2 studies
  1. Medium-chain triglycerides increase knee extension strength in humans.

    “At week 12 of the intervention, all MCT supplement groups showed an increase from baseline in right knee extension strength, compared to the control group.”

    Human trial12-weekn = 120

    Effect of medium-chain triglycerides supplements and walking on health-related quality of life in sedentary, healthy middle-aged, and older adults with low BMIs: a randomized, double-blind, placebo-controlled, parallel-group trial

    Frontiers in nutrition

  2. Medium-chain triglycerides improve knee extension strength in humans.

    “In terms of the change from pre-intake values, the right or bilateral knee extension strength of all MCT intake groups was higher than that of the control group.”

    Human trial12 weeksn = 120

    A Randomized, Double-Blind, Controlled Trial Assessing If Medium-Chain Triglycerides in Combination with Moderate-Intensity Exercise Increase Muscle Strength in Healthy Middle-Aged and Older Adults

    Nutrients

Muscle density

upin humans1

1 study
  1. Medium-chain triglycerides increase muscle density in humans (post-intervention).

    “In addition, MCT increased the post-intervention HU of these two muscles, and a significant difference was detected in the psoas muscle compared to the placebo control.”

    Human trialpost-interventionpsoas and vastus medialis3 consecutive monthsn = 68

    Medium-Chain Triglyceride Dietary Supplements Reduce Glucose Metabolism of Gait-Related Skeletal Muscle in Older Adults: A Longitudinal ¹⁸F-FDG PET/CT Analysis

    Nutrients

  2. Medium-chain triglycerides increase muscle density in humans (healthy) (r = -0.61, r = -0.59, p < 0.001).

    “increased the HU of the psoas (r = -0.61) and vastus medialis muscles (r = -0.59) (p < 0.001)”

    Human trialhealthyjelly stickskeletal muscle18 g/day3 monthsn = 63

    Medium-Chain Triglyceride Dietary Supplements Reduce Glucose Metabolism of Gait-Related Skeletal Muscle in Older Adults: A Longitudinal ¹⁸F-FDG PET/CT Analysis

    Nutrients

Walking speed

upin humans1

1 study
  1. Medium-chain triglycerides improve walking speed in humans (MCTs 0.084 m/s vs. LCTs-0.033 m/s).

    “walking speed (MCTs 0.084 m/s vs. LCTs-0.033 m/s, p = 0.002”

    Human trial3.0-mo intervention

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

  2. Medium-chain triglycerides improve walking speed in humans (relative to 6 g LCTs/day) (p = 0.002).

    “walking speed (p = 0.002)”

    Human trialrelative to 6 g LCTs/day6 g/day3 months

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

Toxicity

downin worms1

1 study
  1. Medium-chain triglycerides decrease toxicity in worms (αSyn-associated toxicity).

    “Supplementing Medium-Chain Triglyceride (MCT) on the other hand also improves αSyn-associated toxicity phenotypes.”

    Model organismsαSyn-associated toxicity

    Alpha-synuclein impairs triglyceride metabolism and mitochondrial structure in aging nematodes

    EMBO reports

Sarcopenia

downin reviews1

1 study
  1. Medium-chain triglycerides protect against sarcopenia.

    “For muscle health, MCTs help optimize energy metabolism and protein homeostasis, showing promise for countering sarcopenia and improving exercise performance.”

    Review

    Recent Advances in Medium-Chain Triglycerides in Chronic Disease Prevention

    Nutrients

More on Sarcopenia

Body mass index

upin humans1

1 study
  1. Medium-chain triglycerides increase body mass index in humans (undernourished or at risk of malnutrition) (from 18.8 ± 2.2 to 19.7 ± 2.3 kg/m2 (p=0.002)).

    “In the intervention group, BMI increased from 18.8 ± 2.2 kg/m2 at baseline to 19.7 ± 2.3 kg/m2 after 5 months”

    Human trialundernourished or at risk of malnutritionsnack containing MCTs (135-136 kcal, 0.4 g protein)10 g/day5 months

    A Pilot Study on the Effects of Medium-Chain Triglyceride-Enriched Oral Nutritional Supplementation on Nutritional Status, Physical Function, and Cognitive Function in Older Facility Residents

    Cureus

More on Body mass index

Triceps skinfold thickness

downin humans1

1 study
  1. Medium-chain triglycerides decrease triceps skinfold thickness in humans (MCTs-1.2 mm vs. LCTs 0.8 mm).

    “In contrast, statistically significant decreases were observed in the right TSF (MCTs-1.2 mm vs. LCTs 0.8 mm, p = 0.016).”

    Human trial3.0-mo intervention

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

More on Triceps skinfold thickness

Muscle mass

upin humans1

1 study
  1. Medium-chain triglycerides increase muscle mass in humans.

    “right AMA (MCTs 1.4 cm2 vs. LCTs-0.7 cm2, p = 0.002”

    Human trial3.0-mo intervention

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

More on Muscle mass

Body weight

upin humans1

1 study
  1. Medium-chain triglycerides increase body weight in humans (MCTs 1.2 kg vs. LCTs 0.2 kg).

    “In the fully adjusted model (model 3), statistically significant increases from baseline in the changes after the 3.0-month intervention in measurements in the MCTs-containing group, relative to the LCTs-containing group, were manifested in body weight (adjusted mean change from baseline: MCTs 1.2 kg vs. LCTs 0.2 kg, p = 0.023”

    Human trial3.0-mo intervention

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

More on Body weight

Triceps skinfold thickness

downin humans1

1 study
  1. Medium-chain triglycerides decrease triceps skinfold thickness in humans (relative to 6 g LCTs/day) (p = 0.016).

    “decreased right triceps skinfold thickness (p = 0.016)”

    Human trialrelative to 6 g LCTs/dayright triceps6 g/day3 months

    Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials

    Frontiers in nutrition

All 29

What is medium-chain triglycerides linked with?

1

Studies link medium-chain triglycerides with cognitive function.

Cognitive function

no changein humans1

1 study
  1. Medium-chain triglycerides are associated with cognitive function in humans (frail elderly nursing home residents) (+1.5 ± 3.0 points (breakfast) and +1.0 ± 2.1 points (dinner), P=0.06).

    “Mini-Mental State Examination score by 1.5 ± 3.0 points (P=0.06) and 1.0 ± 2.1 points (P=0.06)”

    Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37

    Effects of Timing of Medium-Chain Triglycerides (8:0 and 10:0) Supplementation during the Day on Muscle Mass, Function and Cognition in Frail Elderly Adults

    The Journal of frailty & aging

Has medium-chain triglycerides been tested in people?

0 of 2 about aging

Yes: 16 trials and 1 observational study in people have been published, and 2 trials are registered.

In trials

Trial sponsors

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 1Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 1Sep 2026: 4Oct 2026: 2Nov 2026: 015 papers in 12 months

See all 52 papers on medium-chain triglycerides